Posttraumatic reduction of edema with aquaporin-4 RNA interference improves acute and chronic functional recovery

Fukuda, Andrew M; Adami, Arash; Pop, Viorela; Bellone, John A; Coats, Jacqueline S; Hartman, Richard E; Ashwal, Stephen; Obenaus, Andre; Badaut, Jerome
October 2013
Journal of Cerebral Blood Flow & Metabolism;Oct2013, Vol. 33 Issue 10, p1621
Academic Journal
Traumatic brain injury (TBI) is common in young children and adolescents and is associated with long-term disability and mortality. The neuropathologic sequelae that result from juvenile TBI are a complex cascade of events that include edema formation and brain swelling. Brain aquaporin-4 (AQP4) has a key role in edema formation. Thus, development of novel treatments targeting AQP4 to reduce edema could lessen the neuropathologic sequelae. We hypothesized that inhibiting AQP4 expression by injection of small-interfering RNA (siRNA) targeting AQP4 (siAQP4) after juvenile TBI would decrease edema formation, neuroinflammation, neuronal cell death, and improve neurologic outcomes. The siAQP4 or a RNA-induced silencing complex (RISC)-free control siRNA (siGLO) was injected lateral to the trauma site after controlled cortical impact in postnatal day 17 rats. Magnetic resonance imaging, neurologic testing, and immunohistochemistry were performed to assess outcomes. Pups treated with siAQP4 showed acute (3 days after injury) improvements in motor function and in spatial memory at long term (60 days after injury) compared with siGLO-treated animals. These improvements were associated with decreased edema formation, increased microglial activation, decreased blood-brain barrier disruption, reduced astrogliosis and neuronal cell death. The effectiveness of our treatment paradigm was associated with a 30% decrease in AQP4 expression at the injection site.


Related Articles

  • Maximising RNA Interference Specific Knockdown with Minimal Off-target Effects. Ravichandran, Lingamanaidu V.; Beauchamp, Lesslie // Drug Discovery;2010, Vol. 7, p30 

    RNA interference (RNAi) is the mechanism by which the introduction of small interfering RNAs (siRNAs) into cultured cells causes degradation of the complementary messenger RNA (mRNA). RNAi is the method of choice for knocking out the expression of targeted genes. RNAi applications include gene...

  • Systemic Delivery of siRNA Down Regulates Brain Prion Protein and Ameliorates Neuropathology in Prion Disorder. Lehmann, Sylvain; Relano-Gines, Aroa; Resina, Sarah; Brillaud, Elsa; Casanova, Danielle; Vincent, Charles; Hamela, Claire; Poupeau, Sophie; Laffont, Mathieu; Gabelle, Audrey; Delaby, Constance; Belondrade, Maxime; Arnaud, Jacques-Damien; Alvarez, Maria-Teresa; Maurel, Jean-Claude; Maurel, Patrick; Crozet, Carole // PLoS ONE;Feb2014, Vol. 9 Issue 2, p1 

    One of the main challenges for neurodegenerative disorders that are principally incurable is the development of new therapeutic strategies, which raises important medical, scientific and societal issues. Creutzfeldt-Jakob diseases are rare neurodegenerative fatal disorders which today remain...

  • An Arrayed Genome-Scale Lentiviral-Enabled Short Hairpin RNA Screen Identifies Lethal and Rescuer Gene Candidates. Bhinder, Bhavneet; Antczak, Christophe; Ramirez, Christina N.; Shum, David; Liu-Sullivan, Nancy; Radu, Constantin; Frattini, Mark G.; Djaballah, Hakim // Assay & Drug Development Technologies;Apr2013, Vol. 11 Issue 3, p173 

    RNA interference technology is becoming an integral tool for target discovery and validation.; With perhaps the exception of only few studies published using arrayed short hairpin RNA (shRNA) libraries, most of the reports have been either against pooled siRNA or shRNA, or arrayed siRNA...

  • Silencing of mutant p53 by siRNA induces cell cycle arrest and apoptosis in human bladder cancer cells. Hai-Bin Zhu; Kai Yang; Yan-Qi Xie; Yi-Wei Lin; Qi-Qi Mao; Li-Ping Xie // World Journal of Surgical Oncology;2013, Vol. 11 Issue 1, p1 

    Background: p53 is the most frequently mutated tumor-suppressor gene in human cancers. It has been reported that mutations in p53 result not only in the loss of its ability as a tumor suppressor, but also in the gain of novel cancer-related functions that contribute to oncogenesis. The present...

  • RNA interference-based technology: what role in animal agriculture? Bradford, B. J.; Cooper, C. A.; Tizard, M. L.; Doran, T. J.; Hinton, T. M. // Animal Production Science;2017, Vol. 57 Issue 1, p1 

    Animal agriculture faces a broad array of challenges, ranging from disease threats to adverse environmental conditions, while attempting to increase productivity using fewer resources. RNA interference (RNAi) is a biological phenomenon with the potential to provide novel solutions to some of...

  • Exosomes are natural carriers of exogenous siRNA to human cells in vitro. Shtam, Tatyana A.; Kovalev, Roman A.; Yu Varfolomeeva, Elena; Makarov, Evgeny M.; Kil, Yury V.; Filatov, Michael V. // Cell Communication & Signaling;2013, Vol. 11 Issue 1, p1 

    Background Exosomes are nano-sized vesicles of endocytic origin that are involved in cell-to-cell communication including shuttle RNA, mainly mRNA and microRNA. As exosomes naturally carry RNA between cells, these particles might be useful in gene cancer therapy to deliver therapeutic short...

  • Delivery materials for siRNA therapeutics. Kanasty, Rosemary; Dorkin, Joseph Robert; Vegas, Arturo; Anderson, Daniel // Nature Materials;Nov2013, Vol. 12 Issue 11, p967 

    RNA interference (RNAi) has broad potential as a therapeutic to reversibly silence any gene. To achieve the clinical potential of RNAi, delivery materials are required to transport short interfering RNA (siRNA) to the site of action in the cells of target tissues. This Review provides an...

  • RNA interference targeting virion core protein ORF095 inhibits Goatpox virus replication in Vero cells.  // Virology Journal;2012, Vol. 9 Issue 1, p48 

    The article discusses a study which showed the suppression of Goatpox virus (GTPV) replication via knockdown of virion core protein using RNA interference. The study selected four short interfering RNA (siRNA) sequences against a region of GTPV ORF095. The study concluded that vector-based shRNA...

  • Efficient inhibition of HIV-1 replication by an artificial polycistronic miRNA construct. Tao Zhang; Tong Cheng; Lihua Wei; Yijun Cai; Et Yeo, Anthony; Jiahuai Han; Yuan, Y. Adam; Jun Zhang; Ningshao Xia // Virology Journal;2012, Vol. 9 Issue 1, p118 

    Background: RNA interference (RNAi) has been used as a promising approach to inhibit human immunodeficiency virus type 1 (HIV-1) replication for both in vitro and in vivo animal models. However, HIV-1 escape mutants after RNAi treatment have been reported. Expressing multiple small interfering...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics